The global pharmaceutical industry has experienced significant changes in the past few decades, pharmaceutical companies face significant challenges, including headlines trials imminent expiration of patents, new technologies, rising drug development, the total replacement therapy, international competition, and the complex state policy issues. Describes the pharmaceutical industry in 2006, including: the process of drug development, biotechnology and the threat of generic competition; pharmaceutical manufacturing, sales and marketing, as well as drug use in Europe, the Third World, and the U.S. Merck and Pfizer are analyzed in-depth and contrast between Merck, a research firm unlike mergers and Pfizer, as the marketing power grows through acquisitions, developing. Thirteen pieces give specific attention to the case. "Hide
by David J. Collis, Troy Smith Source: Harvard Business School 37 pages. Publication Date: November 27, 2006. Prod. #: 707509-PDF-ENG
Related Case Solutions & Analyses:
Targeting college students on Facebook How to stop wasting your money
Aquion Energy
Stock Reform of Shenzhen Development Bank
Leerink Swann & Co.: Creating Competitive Advantage
Teledesic (Abridged)
Note on Yield Conventions
Recovering Abandoned Compounds Through Expanded External IP Licensing
Nova Chemical Corporation
SAURER: THE CHINA CHALLENGE (A)
ANNOTATED BIBLIOGRAPHY
